Strategies for ascertaining ovarian reserve among women suspected of subfertility

International Journal of Fertility and Women's Medicine

Volumn 45, Issue 3, 2000, Pages 215-224

  Perloe, Mark ^a   Levy, Delphine P ^b,c   Sills, E Scott ^a  

^a Georgia Reproductive Specialists LLC   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

(review article 70 references); Infertility; Ovarian response; Ovulation induction; Screening

Indexed keywords

ADULT; ARTICLE; FEMALE; FEMALE INFERTILITY; HUMAN; OOCYTE; OVARY CYCLE; OVULATION INDUCTION; PRIORITY JOURNAL; SCREENING TEST; SUBFERTILITY;

FEMALE; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVULATION INDUCTION; PREGNANCY;

EID: 0033911198     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Zorn JR: Maternal risks of medical assistance with procreation. Bull Acad Natl Med 179:1743-1750, 1995.
2. Lim SAT, Tsakok MFH: Age-related decline in fertility: a link to degenerative oocytes. Fertil Steril 68:265-271, 1997.
3. Genesis 17:17.
4. Tietze C: Reproductive span and rate of reproduction among Hutterite women. Fertil Steril 8:89-97, 1957.
5. Larsen U, Vaupel JW: Hutterite fecundability by age and parity: strategies for frailty modeling of event histories. Demography 30:81-102, 1993.
6. Romeau A, Muasher SJ, Acosta AA, et al: Results of in vitro fertilization attempts in women 40 years of age and older: the Norfolk experience. Fertil Steril 47:130-136, 1987.
7. Guerin JF, de Mouzon J: Paternal age and fertility. Contracept Fertil Sex 25:515-518, 1997.
8. Virro MR, Shewuck AB: Pregnancy outcome in 242 conceptions after artificial insemination with donor sperm and effects of maternal age on the prognosis for successful pregnancy. Am J Obstet Gynecol 148:518-524, 1984.
9. Padilla SL, Bayati J, Garcia JE: Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 53:288-294, 1990.
10. French national IVF registry: analysis of 1986-1990 data. FIVNAT (French in vitro national). Fertil Steril 59:587-595, 1993.
11. Craft I, Ah-Moye M, Al-Shawaf T, et al: Analysis of 1071 gift procedures - the case for a flexible approach to treatment. Lancet 1(8594):1094-1098, 1988.
12. Smith KE, Buyalos RP: The profound effect of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril 65:35-40, 1996.
13. Rosenwaks Z, Veeck LL, Liu H-C: Pregnancy following transfer of in vitro fertilized donated oocytes. Fertil Steril 45:417-420, 1986.
14. Navot D, Bergh PA, Williams M, et al: An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab 72:408-414, 1991.
15. Moomjy M, Cholst I, Mangieri R, et al: Oocyte donation: insights into implantation. Fertil Steril 71:15-21, 1999.
16. Assisted reproductive technology in the United States and Canada: 1995 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil Steril 69:389-398, 1998.
17. Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertil Steril 71:798-807, 1999.
18. Nasseri A, Mukherjee T, Grifo JA, et al: Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 71:715-718, 1999.
19. Lenton EA, Sexton L, Lee S, et al: Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maturitas 10:35-43, 1988.
20. Jain T, Lee DM, Klein NA, et al: Intercycle variability of day 3 serum FSH levels in normal cumenorrheic young and older women, [abstract P-300]. Fertil Steril 72(Suppl 1):S186, 1999.
21. Barnhart K, Osheroff J: We are overinterpreting the predictive value of serum follicle stimulating hormone levels. Fertil Steril 72:8-9, 1999.
22. Scott RT, Toner JP, Muasher SJ: Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51:651-654, 1989.
23. Toner JP, Philput CB, Jones GS, et al: Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 55:784-791, 1991.
24. Muasher SJ, Oehninger S, Simonetti S, et al: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50:298-307, 1988.
25. Hansen LM, Batzer FR, Gutmann JN, et al: Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 12:486-489, 1997.
26. Brown JR, Liu H-C, Sewitch KF, et al: Variability of day 3 follicle stimulating hormone levels in eumenorrheic women. J Reprod Med 40:620-624, 1995.
27. Martin JS, Nisker JA, Tummon IS, et al: Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle stimulating hormone levels. Fertil Steril 65:1238-1240, 1996.
28. Scott RT, Hofmann GE, Oehninger S, et al: Intercycle variability of day 3 follicle stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 54:297-302, 1990.
29. Lass A, Gerrard A, Brinsden P: IVF treatment in women with 'normal' day 2 FSH levels (<12miu/ml) who had previously high basal FSH levels [abstract P-167]. Fertil Steril 72(Suppl 1):S142, 1999.
30. Metcalf MG, Livesay LH: Gondaotropin excretion in fertile women: effect of age and the onset of the menopausal transition. J Endocrinol 105:357-362, 1985.
31. Lee SJ, Lenton EA, Sexton L, et al: The effect of age on the cyclical patterns of plasma LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3:851-855, 1988.
32. Mukherjee T, Copperman AB, Lapinski R, et al: An elevated day three follicle stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65:588-593, 1996.
33. Licciardi FL, Liu H-C, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticator of ovarian response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64:991-994, 1995.
34. Buyalos RP, Daneshmad S, Brzechffa PR: Basal estradiol and follicle stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril 68:272-277, 1997.
35. Smotrich DB, Widra EA, Gindoff PR, et al: Prognostic value of day three estradiol on in vitro fertilization outcome. Fertil Steril 64:1136-1140, 1995.
36. Evers JL, Slaats P, Land JA, et al: Elevated levels of basal estradiol 17-ß predict poor response in patients with normal basal levels of follicle stimulating hormone undergoing in vitro fertilization. Fertil Steril 69:1010-1014, 1998.
37. Ranieri DM, Quinn F, Makhlouf A, et al: Simultaneous evaluation of basal follicle stimulating hormone and 17-ß estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 70:227-233, 1998.
38. Thatcher SS 3rd, Naftolin F: The aging and aged ovary. Semin Reprod Endocrinol 9:189-199, 1991.
39. Hofmann GE, Scott RT, Jr, Horowitz GM, et al: Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening. Fertil Steril 63:979-983, 1995.
40. Kingsley DM: The TGF-ß superfamily: new members, new receptors and new genetic tests of function in different organisms. Gene Dev 8:133-146, 1994.
41. McCullagh R: Dual endocrine activity of the testes. Science 76:19-20, 1932.
42. De Jong FH, Sharpe RM: Evidence for inhibin-like activity in bovine follicular fluid. Nature 263:71-72, 1976.
43. Vale W, Rivier C, Hsueh A, et al: Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Hormone Res 44:1-30, 1988.
44. Barton DE, Yang-Feng TL, Mason AJ, et al: Mapping of genes for inhibin subunits alpha, beta A, beta B on human and mouse chromosomes and studies of jsd mics. Genomics 5:91-99, 1989.
45. Mathews LS: Activin receptors and cellular signaling by the receptor serine kinase family (review). Endocrinol Rev 15:310-325, 1994.
46. Robertson DM, Klein R, de Vos FI, et al: The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 149:744-749, 1987.
47. Hazout A, Frydman R, Fanchin R, et al: Day 3 serum inhibin-B and estradiol are the best predictors of success in assisted reproductive technologies [abstract O-023]. Fertil Steril 72(Suppl 1):S9, 1999.
48. Smith D, Carr B, O'Neil J, et al: Levels of inhibin A and B in GnRH agonist downregulated women prior to gonadotropin stimulation for in vitro fertilization are highly predictive of pregnancy outcome [abstract O-024]. Fertil Steril 72(Suppl 1):S9-10, 1999.
49. Knight PG, Muttakrishna S, Groome NP: Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 148:267-279, 1996.
50. McConnell DS, Wang Q, Sluss PM, et al: A two-site chemiluminescent assay for actvin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 83:851-858, 1998.
51. Klein NA, Illingworth PJ, Groome NP, et al: Decreased inhibin-B secretion is associated with the monotrophic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745, 1996.
52. Seifer DB, Lambert-Messerlian G, Hogan JW, et al: Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 67:110-114, 1997.
53. Hofmann GE, Danforth DR, Seifer DB: Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 69:474-477, 1998.
54. Renier MA, Vereecken A, Buytaert P: Inhibins, activins and follistatins: a review of complex regulators of the reproductive system. Eur J Contracept Reprod Health 3:129-135, 1998.
55. Seifer DB, Scott RT, Jr, Bergh PA, et al: Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin-B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 72:63-65, 1999.
56. Andolf E, Jorgensen C, Svalenius E, et al: Ultrasound measurement of the ovarian volume. Acta Obstet Gynecol Scand 66:387-389, 1987.
57. Lass A, Skull J, McVeigh E, et al: Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotropin for in vitro fertilization can predict poor response. Hum Reprod 12:294-297, 1997.
58. Danninger B, Brunner M, Obruca A, et al: Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation. Hum Reprod 11:1597-1599, 1996.
59. Thomas C, Nuojua-Huttumen S, Martikainen H: Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in vitro fertilization. Hum Reprod 12:220-223, 1997.
60. Agrawal R, Conway GS, Sladkevicius P, et al: Serum endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clin Endocrinol (Oxf) 50:101-106, 1999.
61. Van Blerkom J: Epigenetic influences on oocyte developmental competence: perifollicular vascularity and intrafollicular oxygen. J Assist Reprod Genet 15:226-234, 1998.
62. Damario M, Moomjy M, Tortoriello D, et al: Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 68:1004-1010, 1997.
63. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 2:645-647, 1987.
64. Loumaye E, Billion JM, Mine JM, et al: Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 53:295-301, 1990.
65. Tanbo T, Dale PO, Lunde O, et al: Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle stimulating hormone levels. Fertil Steril 53:295-301, 1990.
66. Tanbo T, Dale PO, Lunde O, et al: Prediction of individual response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle stimulating hormone levels. Fertil Steril 57:819-824, 1992.
67. Scott RT, Leonardi MR, Hofmann GE, et al: A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol 82:539-544, 1993.
68. Kahraman S, Vicdan K, Isik AZ, et al: Clomiphene citrate challenge test in the assessment of ovarian reserve before controlled ovarian hyperstimulation for intracytoplasmic sperm injection. Eur J Obstet Gynecol Reprod Biol 73:177-182, 1997.
69. Garcia JE: Gonadotropin-releasing hormone and its analogues: applications in gynecology. Clin Obstet Gynecol 36:719-726, 1993.
70. Winslow KL, Toner JP, Brzyski RG, et al: The gonadotropin-releasing hormone agonist stimulation test: a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 56:711-717, 1991.